Item Brochure
Frequent Uses
General so tissue approximation including fascia closure, Orthopedic surgery, Pediatric Cardiovascular surgery
and patients with compromised wound healing.
Indications
Maxon™ and Maxon™ CV synthetic absorbable sutures are indicated for use in general so tissue approximation
and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in
peripheral vascular surgery. Maxon™ and Maxon™ CV synthetic absorbable sutures are not indicated for use in adult
cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues.
Specifications
†
Composition Glycolide and Trimetheylene Carbonate
Sizes Available in USP sizes to 7-0 to 1
Color Green and Clear
Absorption Prole 180 Days
Tensile Strength 80% of initial tensile strength retained at 1 week, 75% at 2 weeks,
65% at 3 weeks, 50% at 4 weeks and 25% at 6 weeks post implant
Maxon
™
Is Stronger Than The Competition During The Critical Wound Healing Period
Learn more: www.covidien.com/syneture
or place your order at: 1 800 722 8772.
Maxon
™
Competitive
Absorbable
Monofilament
USP KNOT PULL FORCE (KG)
8
7
6
5
4
3
2
1
Maxon
™
Suture – Initial Strength (Size 0)
67% Stronger than the Competition
*Strength During Critical Wound Healing (Size 0)
4
8
12
1
0 1 2 3 4 5
Competitive
Absorbable
Monofilament
Maxon
™
WEEKS IN VITRO @ 37°C
STRAIGHT PULL FORCE (KG)
COVIDIEN, COVIDIEN with logo and “positive results for life” are trademarks of Covidien AG.
© 2008 Covidien AG or its affiliates. All rights reserved.
378969 SS 2.5M 08.08 CSS000170i
†
Refer to the package insert for complete product details